Lindsey Dayer

Lindsey Dayer, Pharm.D., BCACP, serves as Associate Professor and Director of Experiential Education in the Department of Pharmacy Practice at the University of Arkansas for Medical Sciences (UAMS) College of Pharmacy. She concurrently works as a Clinical Pharmacist in the Sickle Cell Clinic at UAMS Cancer Institute since 2016.

Education Background

• Pharmacy Practice Residency, UAMS Hospital, Little Rock (2009-2010)
• Doctor of Pharmacy, UAMS College of Pharmacy (2005-2009)
• Bachelor of Science in Biology, University of the Ozarks (2001-2005)

Research Focus

Dr. Dayer's scholarship centers on two critical domains: experiential education innovation addressing preceptor challenges, student remediation, and virtual simulation development; and opioid safety research investigating medication interactions (opioids with gabapentinoids/skeletal muscle relaxants), fall risks in elderly populations, and pain management in cancer survivors and sickle cell disease. Her work frequently employs large-scale administrative datasets and interprofessional collaboration.

Publication Trends

Analysis of her 15 most recent publications (2023-2025) reveals intensifying focus on opioid stewardship in vulnerable populations (older adults, cancer survivors) and technological innovation in pharmacy education. Over 60% of recent works examine adverse outcomes from polypharmacy involving opioids, while experiential education studies increasingly incorporate immersive simulations (escape rooms, virtual platforms) to address preceptor shortages and student anxiety.

Scientific Recognition

• Award for Excellence in Experiential Education, AACP Section (2020-21)
• AAHP Fall Seminar 1st Place Poster (2021)
• AR-ACCP New Investigator Award (2016)

Academic Leadership

As Director of Experiential Education, Dr. Dayer oversees all clinical rotations while mentoring student research through PHPR 7364 Special Problems courses. Her interprofessional naloxone training initiative demonstrates grant-funded collaboration across nursing, medicine, and public health disciplines, directly translating research into overdose prevention practice.

Clinical Integration

Her dual role in the Sickle Cell Clinic and Cancer Institute creates a direct pipeline between clinical observations and research questions, particularly regarding hydroxyurea dosing effects and neuropathic pain management in hematology-oncology populations.